News Articles
Latest articles, insights, and updates from the blog.
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.

Patients Say Ketamine Beats Years on Prozac, NY Post Reports
Patients report ketamine beat years of Prozac, per a 2026 NY Post report. Learn the difference between FDA-approved esketamine and off-label ketamine care.
Depression Field Shifts From Resistant to Difficult-to-Treat
Psychiatric Times says 'treatment-resistant depression' should become 'difficult-to-treat depression.' What that means for ketamine patients.
Esketamine vs. Ketamine: Why the Rules Still Differ
A psychiatrist with 7 years of esketamine experience questions why off-label ketamine escapes the same oversight. Here's what it means for patients in 2026.
1 in 3 Don't Respond to Antidepressants: What's Next
Nearly 1 in 3 patients don't respond to antidepressants, per Men's Journal. Here's what ketamine treatment offers when standard drugs fail in 2026.
Ketamine and Aging Brains: What a New Study Signals
Futurity reports a new study on how ketamine affects brain activity in older adults. Here's what's known, what's unclear, and what to ask your provider.
FDA Flags Alar's Ketamine Marketing Claims as Risky
The FDA has raised concerns about ketamine marketing claims made by Alar, per an Aug. 31, 2026 Fierce Pharma report. Here's what it means for patients.
Medscape Asks: Does Therapy Boost Ketamine's Benefits?
Medscape spotlighted ketamine-assisted psychotherapy on Aug. 31, 2026. Here's what the question means for telehealth ketamine patients and providers.
HRSA Psychedelic Therapy RFI: What It Means for Patients
HRSA's RFI on psychedelic therapy training and delivery drew 59 comments. Here's what it could mean for ketamine clinic patients and access.
Calliope Health Cites Ketamine-Sleep Research in Depression
New research cited by Calliope Health links ketamine treatment to improved sleep in depression patients, here's what it means for telehealth care.
Why Ketamine and Esketamine Doses Aren't Interchangeable
Nature researchers warn that ketamine and esketamine doses are often confused, a mix-up that can affect safety and cost for telehealth patients.
Treatment-Resistant Depression: What Comes Next
STAT explores options when antidepressants stop working. Here's what treatment-resistant depression means and where ketamine therapy fits in care planning.
Federal Probe Targets Online Ketamine Sellers
Federal officials are investigating online ketamine sellers to limit at-home use, per a WSJ exclusive. Here's what patients and providers need to know.
FDA Ketamine Crackdown: What Patients Should Know
FDA enforcement against illegal ketamine sellers is rising. Learn what this means for patients vetting legitimate telehealth ketamine providers.